Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones
The purpose of this Notice is to inform potential applicants of an area of special interest in developing tools for continuous monitoring of circulating or interstitial nutrients, metabolites or hormones relevant to diet and nutrition.
Funding Opportunity Details
NOT-DK-20-002
PA-19-270; PA-19-272; PA-19-273; NOT-DK-19-021
Christopher J. Lynch, Ph.D.
Key Dates
11/6/2019
Read full announcement
This notice applies to due dates on or after January 5, 2020 and subsequent receipt dates through January 8, 2023.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
- R43/R44
- PA-19-272: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- January 5, 2020
- PA-19-272: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- R41/R42
- PA-19-270: PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- January 5, 2020
- R43/R44
- PA-19-273: PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- January 5, 2020
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
- For funding consideration, applicants must include “NOT-DK-20-002” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
Investigators planning to submit an application in response to this NOSI are strongly encouraged to contact and discuss their proposed research/aims with the program officer listed on this NOSI in advance of the grant receipt date.
Applications non-responsive to terms of this NOSI will be not be considered for the NOSI initiative.
Applications non-responsive to terms of this NOSI will be not be considered for the NOSI initiative.